Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women

BMC Public Health

Karen Odberg Pettersson¹  Per Olof Ostergren¹  Chidinma V Gab-Okafor²  Oliver C Ezechi¹ 

[1] Division of Social Medicine and Global Health, Faculty of Medicine, Lund University, Lund, Sweden;Clinical Sciences Division, Nigerian Institute of Medical Research, Lagos, Nigeria

关键词: Acceptability;    HIV;    Screening;    Cervical cancer;   

Others  :  1162633
DOI  :  10.1186/1471-2458-13-46

 received in 2012-08-21, accepted in 2013-01-08,  发布年份 2013

【 摘 要 】

Background

The proven benefit of integrating cervical cancer screening programme into HIV care has led to its adoption as a standard of care. However this is not operational in most HIV clinics in Nigeria. Of the various reasons given for non-implementation, none is backed by scientific evidence. This study was conducted to assess the willingness and acceptability of cervical cancer screening among HIV positive Nigerian women.

Methods

A cross sectional study of HIV positive women attending a large HIV treatment centre in Lagos, Nigeria. Respondents were identified using stratified sampling method. A pretested questionnaire was used to obtain information by trained research assistants. Obtained information were coded and managed using SPSS for windows version 19. Multivariate logistic regression model was used to determine independent predictor for acceptance of cervical cancer screening.

Results

Of the 1517 respondents that returned completed questionnaires, 853 (56.2%) were aware of cervical cancer. Though previous cervical cancer screening was low at 9.4%, 79.8% (1210) accepted to take the test. Cost of the test (35.2%) and religious denial (14.0%) were the most common reasons given for refusal to take the test. After controlling for confounding variables in a multivariate logistic regression model, having a tertiary education (OR = 1.4; 95% CI: 1.03-1.84), no living child (OR: 1.5; 95% CI: 1.1-2.0), recent HIV diagnosis (OR: 1.5; 95% CI: 1.1-2.0) and being aware of cervical cancer (OR: 1.5; 95% CI: 1.2-2.0) retained independent association with acceptance to screen for cervical cancer.

Conclusions

The study shows that HIV positive women in our environment are willing to screen for cervical cancer and that the integration of reproductive health service into existing HIV programmes will strengthen rather than disrupt the services.

【 授权许可】

   
2013 Ezechi et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Anorlu RI: Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters 2008, 16(32):41-49.
• [2]Okonofua F: HPV vaccines and prevention of cervical cancer in Africa. Afr J Reprod Health 2007, 11:7-9.
• [3]Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H, et al.: Cancer in Africa: epidemiology and prevention. IARC Press Publication No. 153, Lyon; 2003:23-25.
• [4]Akinola OI, Fabamwo AO, Oshodi YA, Banjo AA, Odusanya O, Gbadegesin A, et al.: Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology. J Obstet Gynaecol 2007, 27:703-705.
• [5]Adu RA, Ezechi OC, Onwujekwe DI, Odunukwe NN, David AN, Kalejaiye OO, et al.: The changing pattern of HIV related deaths in south western Nigeria. Abuja: 5th National Conference on HIV/AIDS; 2010. 2-5th May 2010. Abstract number WeOrB03,04
• [6]Ezechi OC, Odberg Pettersson K, Byamugisha J: HIV/AIDS, Tuberculosis, and Malaria in Pregnancy. Journal of Pregnancy 2012, 2012:3.
• [7]Parhama GP, Sahasrabuddhe VV, Mwanahamuntud MH, Shepherd BH, Hickse ML, Stringera EM, et al.: Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006, 103(3):1017-1022.
• [8]Agaba PA, Thacher TD, Ekwempu CC, Idoko JA: Cervical dysplasia in Nigerian women Infected with HIV. Int J Gynecol Obstet 2009, 107:99-102.
• [9]Lusti-Narasimham M, Say L, Mbizo MT: Linking HIV and sexual and reproductive health services to enhance program outcomes. Int J Gynecol Obstet 2010, 110:S7-S9.
• [10]Federal Ministry of Health, Nigeria (FMoH): National guidelines for HIV and AIDs treatment and care in adolescents and adults. Abuja Nigeria: FMoH; 2010.
• [11]Chama CM, Nggada H, Gaushau W: Cervical dysplasia in HIV infected women in Maiduguri. Nigerian Journal of Obstetrics and Gynaecology 2005, 25(3):286-288.
• [12]Nnodu O, Erinosho L, Jamda M, Olaniya O, Adelaiye R, Lawson L, et al.: Knowledge and Attitudes towards Cervical Cancer and Human Papillomavirus: A Nigerian Pilot Study. Afr J Reprod Health 2010, 14(1):95-108.
• [13]Dim CC, Dim NR, Ezegwui HU, Ikeme AC: An Unmet Cancer Screening Need of HIV-Positive Women in Southeastern Nigeria. Medscape J Med 2009, 11(1):19.
• [14]Batra P, Kuhn L, Denny L: Utilization and outcome of cervical prevention services among HIV infected women in Cape Town. South African Medical Journal 2010, 100(1):39-44.
• [15]Abotchie PN, Shokar NK: Cervical cancer screening among college students in Ghana: knowledge and health beliefs. Int J Gynecol Cancer 2009, 19(3):412-416.
• [16]Were E, Nyaberi Z, Buziba N: Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital, Eldoret, Kenya. Afr Health Sci 2011, 11(1):58-64.
• [17]Wright KO, Kuyinu YA, Faduyile FA: Community education on cervical cancer amongst market women in an urban area of Lagos, Nigeria. Asian Pac J Cancer Prev 2010, 10:137-140.
• [18]Raosoft Incorporated: Raosoft Sample size calculator 2004. Available from URL: http://www.raosoft.com/samplesize.html webcite
• [19]Ezem BU: Awareness and uptake of cervical cancer screening in Owerri, South-Eastern Nigeria. Ann Afr Med 2007, 6(3):94-98.
• [20]Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, Chibwesha C: Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Ther 2010, 4(6):713-722.
• [21]Bukar M, Audu BM: Women’s attitude towards cervical cancer screening in North Eastern Nigeria. Nigerian Medical Practioners 2011, 60(1):13-18.
• [22]Dim CC, Nwagha UI, Ezegwui HU, Dim NR: The need to incorporate routine cervical cancer counselling and screening in the management of women at the the outpatient clinics in Nigeria. J Obstet Gynaecol 2009, 29:754-756.
• [23]McKenzie K, Rogers R, Pamnani R, Warui D, Sakr S, Ngumo R, et al.: Free cervical cancer screening among HIV positive women receiving antiretroviral treatment in Kenya: acceptance and findings. 5th IAS Conference on HIV Pathogenesis and Treatment: Abstract no. WEPEB247; 2007.
• [24]Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, Yood MU, Gilbert J, Taplin SH: Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process. J Natl Cancer Inst 2005, 97:675-683.
• [25]Fylkesnes K, Siziya S: A randomized trial on acceptability of voluntary HIV counselling and testing. Trop Med Int Health 2004, 9(5):566-572.
• [26]Mckenzie K, Warui D, Sakr S, Ngumo R, Rana FS, Mugo N, John-Stewart GC, Chung MH: Free cervical cancer screening among HIV positive women receiving antiretroviral treatment in Kenya: Acceptance and Findings. Cape Town: Paper presented at the 5th IAS conference on HIV pathogenesis and treatment; 2009. Abstract no. WEPEB247